Stockwinners Market Radar for June 13, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:42 EDT Arm to join Nasdaq-100 index, replacing Sirius XM - Nasdaq announced that Arm Holdings plc (ARM), will become a component of the Nasdaq-100 Index, the Nasdaq-100 Equal Weighted Index, the Nasdaq-100 Tech Sector Index, the Nasdaq-100 Technology Sector Market-Cap Weighted Index , and the Nasdaq-100 Technology Sector Adjusted Market-Cap Weighted Index prior to market open on Monday, June 24, 2024. Arm Holdings plc will replace Sirius XM Holdings Inc. (SIRI) in the Nasdaq-100 Index and the Nasdaq-100 Equal Weighted Index. Sirius XM will also be removed from the Nasdaq-100 Ex-Tech Sector Index, the Nasdaq-100 ESG Index, the Nasdaq-100 Sustainable ESG Select Index, and the Nasdaq-100 Target 25 Index on the same date.

19:50 EDT 2U trading halted, news pending

19:43 EDT BeiGene, NewBridge Pharmaceuticals to conclude BRUKINSA pact in MENA - The company stated: "BeiGene and NewBridge Pharmaceuticals have jointly decided to conclude their partnership. This strategic decision aligns with BeiGene's goals to expand its presence and directly manage operations in the MENA region. The collaboration between the two companies began in 2020 and included sales, distribution, and commercialization activities for BRUKINSA in the MENA region. As a result of the partnership, BRUKINSA has been approved by the health authorities in multiple territories and is currently marketed in several regions with additional approvals to come. The separation is well planned, with timelines determined on a country-by-country basis starting in June 2024 and completing by March 31, 2025. Whilst the distribution agreement has been agreed by the parties to terminate on March 31, 2025, all customer-facing activities will be taken over by BeiGene from June 11, 2024, including Medical Affairs, Commercial Operations and Market Access, with BeiGene utilizing the expanded team it is building in the region. This strategic shift represents a significant milestone for BeiGene as it expands its global presence. By 2025, the company aims to achieve groundbreaking advancements in the treatment of solid tumors and hematological cancers, reinforcing its dedication to providing cutting-edge cancer therapies worldwide. This move underscores BeiGene's commitment to delivering innovative and transformative treatments to cancer patients globally."

18:38 EDT GitLab CFO Robins sells 11,667 class A shares - In a regulatory filing, Gitlab CFO Brian Robins disclosed the sale of 11,667 class A common shares of the company on June 12 at a price of $45.46 per share.

17:51 EDT GXO Logistics CEO buys $499.5K in common stock - In a regulatory filing, GXO Logistics disclosed that its CEO Malcolm Wilson bought 10K shares of common stock on June 11th in a total transaction size of $499.5K. Shares of GXO Logistics are up 1.4% afterhours at $50.15.

17:49 EDT Pegasystems director buys $504.2K in common stock - In a regulatory filing, Pegasystems disclosed that its director Sharon Rowlands bought 8.6K shares of common stock on June 11th in a total transaction size of $504.2K. Shares of Pegasystems are up 4.1% afterhours at $59.60.

17:44 EDT Re/Max: New listings rose 15.1% in May, home sales grew 0.7% y/y - In May, both inventory and new listings grew to levels not seen since the second half of 2022. The number of homes for sale, as surveyed across 53 metro areas, also increased, rising 8.7% over April and 39.6% year over year. And for the third consecutive month, the number of new listings exceeded 2023 levels by double-digit percentages - 15.1% in May, 18.2% in April, and 17.6% in March.Fueled by the 22-month high in new listings, May home sales grew 10.9% over April and 0.7% over last May. Monthly home sales in 2024 have now exceeded the 2023 monthly sales totals for four of the five months. The Median Sale Price increased 2.4% over April to $435,000. That was 4.8% higher than May 2023. The close-to-list price ratio remained at the 100% level it reached in April following eight months at 99% or less. "More sellers are seeing the advantages of listing their homes now. They're getting their asking price and enjoying the benefits of a relatively quick sale," said Amy Lessinger, President of RE/MAX, LLC. "Growing inventory offers more options for homebuyers, too, and we're seeing more sales activity as a result. Mortgage rates continue to impact the rhythm of the housing market. If inventory keeps bulking up and mortgage rates don't change, prices may eventually start to soften."

17:35 EDT Mineralys Therapeutics CFO Levy sells 96,815 common shares - In a regulatory filing, Mineralys Therapeutics CFO Adam Scott Levy disclosed the sale of 96,815 common shares of the company on June 11 at a price of $12.9393 per share.

17:22 EDT Perspective Therapeutics CEO buys $117.4K in common stock - In a regulatory filing, Perspective Therapeutics disclosed that its CEO Johan Spoor bought 100K shares of common stock on June 13th in a total transaction size of $117.4K. Shares of Perspective Therapeutics are up 8% afterhours at $1.25.

17:09 EDT Adobe sees Q3 digital media annual recurring revenue $460M of net new ARR - Sees Q3 tax rate 18.5%. Sees FY24 digital media annual recurring revenue, or ARR, $1.95B of net new ARR. Sees FY24 tax rate 18.5%. Says extending applications to integrate third-party text, image and video models and partnering strategically to create multi-modal large language models. Says vision for Adobe Express is to provide a breakthrough application to make design easy for communicators worldwide, leveraging generative AI. Says pleased to raise annual net new ARR target to $1.95B. Comments and guidance taken from Q2 earnings conference call.

16:54 EDT RH down 10% at $249.10 after Q1 earnings miss

16:52 EDT On Semiconductor CFO Thad Trent sells $2.8M in company shares - CFO of ON Semiconductor Thad Trent disclosed the sale of 38,000 shares of company stock at $72.55 per share on June 11, for a total transaction amount of $2,756,938.

16:49 EDT Bristol Myers says FDA grants accelerated approval of Augtyro - Bristol Myers Squibb announced that the U.S. FDA has granted accelerated approval of Augtyro for the treatment of adult and pediatric patients 12 years of age and older with solid tumors that have a neurotrophic tyrosine receptor kinase gene fusion, are locally advanced or metastatic or where surgical resection is likely to result in severe morbidity, and have progressed following treatment or have no satisfactory alternative therapy. The approval is based on results from the Phase 1/2 TRIDENT-1 study, which evaluated Augtyro in adult patients with NTRK-positive solid tumors. This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in the confirmatory trials

16:32 EDT W.P. Carey raises quarterly dividend to 87c per share - W. P. Carey reported that its Board of Directors increased its quarterly cash dividend to 87c per share, equivalent to an annualized dividend rate of $3.48 per share. The dividend is payable on July 15 to stockholders of record as of June 28.

16:31 EDT Granite awarded roughly $15M contract by Caltrans - Granite has been awarded an approximately $15M contract by the California Department of Transportation to rehabilitate pavement along State Route 41 near Stratford, California. Project funding comes from Caltrans and will be included in Granite's second-quarter CAP. This project aims to rehabilitate the pavement, providing a smoother ride and reducing maintenance demands. The rehabilitation will involve removing and replacing failed pavement areas with 49,400 tons of Hot Mix Asphalt and then placing a surface course of 19,100 tons of Rubberized Hot Mix Asphalt which will be supplied by Granite's Coalinga plant in Fresno County, California. In addition to the pavement rehabilitation, culverts along the route will be lengthened and rehabilitated, guard railing and barriers will be upgraded, and failing bridge approaches pavement will be replaced with concrete approaches slabs. "Our team is proud to take on the challenge of enhancing SR41, a vital connector between the Central Valley and the Central Coast," said Carter Rohrbough, Granite Vice President of Regional Operations. "With numerous pavement failures impacting this heavily traveled two-lane highway, we're committed to delivering smoother roads and reducing maintenance burdens for Caltrans crews. Our expertise and dedication will ensure a safer and more efficient journey for all travelers."

16:19 EDT NYSE American to commence delisting proceedings against Nuburu - NYSE American announced that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock of Nuburu, - ticker symbol BURU - from NYSE American. Trading in the company's common stock will be suspended immediately. "NYSE Regulation has determined that the company is no longer suitable for listing pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the common stock. The company has a right to a review of staff's determination to delist the common stock by the Listings Qualifications Panel of the Committee for Review of the Board of Directors of the Exchange. The NYSE American will apply to the Securities and Exchange Commission to delist the company's common stock upon completion of all applicable procedures, including any appeal by the company of the NYSE Regulation staff's decision," the exchange stated. Reference Link

16:17 EDT Atlantic Coastal Acquisition II receives delayed filing notice from Nasdaq - Atlantic Coastal Acquisition II received written notification from Nasdaq on June 3 that, because the company had not yet filed its Quarterly Report on Form 10-Q for the three month period ended March 31, 2024 with the SEC, the company was not in compliance with Nasdaq's continued listing requirements. The company has 60 calendar days from the date of the notice to provide Nasdaq with a specific plan to achieve and sustain compliance. The company expects to file the 10-Q in the coming weeks.

16:15 EDT Chimera raises quarterly dividend to 35c per share from 33c - The dividend is payable July 31, 2024 to common stockholders of record on June 28, 2024.

16:12 EDT AG Mortgage raises quarterly dividend by 5.6% to 19c per share - The dividend is payable on July 31, 2024 to shareholders of record at the close of business on June 28, 2024.

16:07 EDT Adobe reports Q2 Remaining Performance Obligations $17.86B

16:06 EDT Beyond Air appoints David Webster as chief commercial officer - Beyond Air announced the appointment of David Webster as chief commercial officer of the company, effective July 8. Webster has developed and executed several commercial strategies for medical devices and therapeutics, primarily in the hospital space.

15:41 EDT Teleflex recalls catheter kits due to overtwisting risk - Teleflex and its subsidiary Arrow International are recalling the Arrow FiberOptix Intra-Aortic Balloon Catheter Kit and Arrow UltraFlex Intra-Aortic Balloon Catheter Kits after finding that a manufacturing error may cause the catheter's balloon to become overtwisted. The issue can sometimes be identified visually, but a device may still be impacted even if the issue cannot be detected visually and all mitigations outlined in this recall should be followed. This issue may: prevent the balloon from fully inflating, cause blood to back up in the tubing, allow helium to leak, and lead to catheter damage or insertion difficulty during use. Use of this device may cause serious injury, including blood loss, tearing in the artery, unstable blood pressure, prevention of blood flow to the heart, or death. Teleflex/Arrow International reports 322 complaints. A total of 31 injuries and 3 deaths have been reported potentially related to this issue. The company said 16,959 of such devices are being recalled in the U.S.

14:53 EDT Meta's WhatsApp updates video calling experience up to 32 people - "Since we brought Calling to WhatsApp back in 2015, we've continued to improve it with the introduction of group calls, video calls, and multi-platform support. Today we have several updates that will make calls across your devices even bigger and better, rolling out over the next few weeks: Screen sharing with audio: Ideal for watching videos together, now when you share your screen, you can share your audio too; More participants: Now you can have up to 32 people on a video call across all your devices; Speaker spotlight: Easily see who's talking with the speaker automatically highlighted and appearing first on screen," blogged the instant messaging app, in part, earlier on Thursday. Reference Link

14:24 EDT Occidental Petroleum holder Warren Buffett buys over $105M in shares - Occidental Petroleum holder Warren Buffett purchased 1,750,308 shares of company stock at $60.30 per share between June 10 and June 12 for a total transaction amount of $105,550,574.

13:43 EDT Tyson confirms suspension of CFO following alleged DWI arrest - Tyson Foods said in a statement: "We are aware that John Randal Tyson, Chief Financial Officer of Tyson Foods, was arrested for an alleged DWI. Tyson Foods has suspended Mr. Tyson from his duties effective immediately and named Curt Calaway as interim Chief Financial Officer." Reference Link

13:09 EDT Xbox's 'Sea of Thieves' most downloaded PS5 game in May in U.S., EU, Canada - Sony (SONY) said that the most downloaded game for PlayStation 5 on the PS Store for the month of May in the EU, U.S., and Canada was Microsoft's (MSFT) "Sea of Thieves." The Fly notes that "Sea of Thieves" was originally an Xbox console exclusive when it released in 2018, but was ported to PlayStation this past April. Other top-downloaded games on the PS Store for the PS5 in May in the EU, U.S., and Canada were Electronic Arts' (EA) "Madden NFL 24" and "F1 24," Take-Two's "Grand Theft Auto V," Take-Two's (TTWO) "NBA 2K24" and "Grand Theft Auto V," Activision's "Call of Duty: Modern Warfare III," and Ubisoft's (UBSFY) "Assassin's Creed Mirage." Reference Link

12:39 EDT LM Funding America trading halted, volatility trading pause

12:11 EDT Peloton instructor Kendall Toole announces departure from company - Peloton instructor Kendall Toole announced in a Reel on Instagram on Thursday that she is leaving the company after nearly five years. "It's with great consideration and many, many, many hours of reflection, but I'm choosing to close my chapter at Peloton," said Toole, who leads cycling, boxing and strength workouts on the platform. Shares of Peloton are down nearly 5% at midday to $3.69. Reference Link

12:04 EDT Grupo Supervielle rises 10.7% - Grupo Supervielle is up 10.7%, or 70c to $7.26.

12:03 EDT Barnes & Noble Education rises 17.1% - Barnes & Noble Education is up 17.1%, or $1.20 to $8.19.

12:02 EDT Signet Jewelers falls -15.5% - Signet Jewelers is down -15.5%, or -$16.77 to $91.65.

12:00 EDT ZKH Group falls -36.9% - ZKH Group is down -36.9%, or -$2.12 to $3.62.

11:56 EDT J & J Snack Foods enters long-term partnership wih Slick City - J&J Snack Foods Corp. announced a long-term partnership with Slick City. The partnership will bring J&J Snack Foods' brands Dippin' Dots, Hola! Churros, SUPERPRETZEL, and ICEE to Slick City locations nationwide. The brands are available now at all open Slick City locations in Denver, CO, St. Louis, MO, Katy, TX, and the new Peoria, AZ location. The full snack portfolio will be available at four new Slick City locations in Denton, TX, North Aurora, IL, Wauwatosa, WI and Houston, TX as they continue to open throughout the year.

11:00 EDT ASP Isotopes appoints Heather Kiessling as CFO - ASP Isotopes announced the appointment of Heather Kiessling as its Chief Financial Officer, effective as of July 1, or such earlier date as may be mutually agreed, to support the company's next pivotal phase of growth. Robert Ainscow, who currently serves as the company's CFO and Chief Operating Officer, will continue to serve as the company's COO, enabling him to focus his full time and attention on the company's operations and strategic initiatives, ASP Isotopes stated. Ms. Kiessling has joined the company from Danforth Advisors LLC, a life science financial strategy consultancy, where she has been providing consulting and advisory services to ASP Isotopes since November 2021. "We have been laser-focused on cost management since the Company's inception and have outsourced many roles. As the company progresses from being a pre-commercial company to a company generating revenues, we require greater financial infrastructure," said Paul Mann, Executive Chairman and Chief Executive Officer of ASP Isotopes.

10:53 EDT UroGen Pharma to resume trading at 11:15 am ET - UroGen Pharma shares are scheduled to resume trading at 11:15 am ET, with quotation set to resume at 11:10 am ET, according to Nasdaq. Shares had been halted, pending news, ahead of the company announcing 82.3% 12-month duration of response data by Kaplan-Meier estimate from its Phase 3 ENVISION trial in patients who achieved complete response at three months after the first instillation of investigational drug UGN-102 for intravesical solution.

10:40 EDT UroGen Pharma trading halted, news pending

10:04 EDT Wiley rises 15.3% - Wiley is up 15.3%, or $5.59 to $42.07.

10:03 EDT Epam Systems acquires health data analytics company Odysseus Data - EPAM Systems announced its acquisition of Odysseus Data Services, Inc., a health data analytics company. Odysseus will expand EPAM's ability to transform the life sciences value chain through advanced data analytics, data methods and artificial intelligence. "We are pleased to have Odysseus join EPAM. With their strong capabilities in Real-World Evidence and Real-World Data - the 'glue' between multiple segments of the life sciences value chain - our natural synergies make this an exciting time to add this to our portfolio to help our clients achieve better outcomes," said Greg Killian, Senior Vice President of Life Sciences at EPAM.

10:02 EDT Agco dealership launches same-day parts delivery service - Agco announced the launch of AgRevolution's same-day delivery service for machinery parts. AgRevolution, an Agco-owned, full-line agricultural equipment dealer operating in Kentucky, Illinois and Indiana, now offers farmers same-day delivery in as little as two hours for in-stock parts.

10:01 EDT ZKH Group falls -18.6% - ZKH Group is down -18.6%, or -$1.07 to $4.67.

09:51 EDT Gold Fields falls -7.9% - Gold Fields is down -7.9%, or -$1.25 to $14.59.

09:49 EDT J.Jill falls -16.9% - J.Jill is down -16.9%, or -$6.67 to $32.88.

09:48 EDT Grupo Supervielle rises 10.1% - Grupo Supervielle is up 10.1%, or 66c to $7.22.

09:36 EDT Knightscope announces U.S. bank subscribes to K5 ASR service - Knightscope announces that a top-50 US bank executed an agreement subscribing to Knightscope's K5 Autonomous Security Robot service. The initial deployment will take place at one of its Kansas City locations.

09:34 EDT Bollinger Motors to sell 80 B4 chassis cabs to Momentum Groups - Bollinger Motors has reached an agreement to sell 80 all-electric Class 4 commercial trucks to Momentum. Momentum Groups can upfit the Bollinger B4 Chassis Cab with mobile EV chargers, a box truck, flatbed, service body or stake truck. Momentum Groups' strength is in their full-service national fleet program, and mobile or permanent charging infrastructure for Electric Vehicles. Momentum will take possession of the vehicles after Bollinger Motors launches production in the second half of 2024.

09:31 EDT National Fuel increases quarterly dividend 4% to 51.5c per share - The National Fuel Gas Company Board of Directors approved a 4.0% increase in the dividend on the Company's common stock, raising the quarterly rate from 49.5 cents per share as approved in June 2023 to 51.5 cents per share for an annual rate of $2.06 per share.

09:26 EDT Revelation Biosciences completes enrollment in Gemini study - Revelation Biosciences announced that it has completed enrollment and dosing of its first in human Phase 1 clinical study. The study, which was conducted in Australia, evaluated escalating doses of intravenously administered Gemini and enrolled 40 healthy individuals 18 to 55 years of age. The forthcoming top-line data will include primary end points of safety and tolerability along with exploratory endpoints including multiple biomarkers of activity to demonstrate stimulation of the innate immune response. If positive, the data from this Phase 1 clinical study will support future program development of Gemini across multiple indications.

09:25 EDT Liberty Global to acquire shares in Formula E from Warner Bros. Discovery - Liberty Global (LBTYA) announced it is to acquire shares held by Warner Bros. Discovery (WBD) in the electric car racing series Formula E. The acquisition of shares held by Warner Bros. Discovery will, on completion, bring Liberty Global's total share of ownership in Formula E to 65% and mean that Liberty Global will take a controlling interest in the motorsport.

09:21 EDT GlucoTrack completes preclinical study of epidural glucose monitoring sensor - Glucotrack announced that its implantable continuous glucose monitor has completed a 60-day long-term preclinical study demonstrating the feasibility of glucose monitoring in the epidural space. The Glucotrack sensor, implanted in the epidural space of animals, closely tracked glucose values from both a commercially available blood glucose monitor and a subcutaneous continuous glucose monitor throughout the 60-day period. No abnormal clinical signs were observed throughout the study period, and no abnormal findings were observed in the spinal cord or surrounding tissues during post-explant analysis. The study also confirmed that the implanted sensor did not cause any delayed latent effects over the long-term period, which is particularly important as a complete healing process in animal studies with implanted devices may take several weeks. Glucotrack previously announced interim performance and safety results from this long-term animal study assessing sustained epidural glucose monitoring performance. With the completion of this study, the durability of the epidural approach for continuous glucose monitoring has now been confirmed over the 60-day period.

09:19 EDT Mullen's Bollinger Motors receives $13.2M sales order - Mullen Automotive announces that its subsidiary, Bollinger Motors, has reached an agreement to sell 80 all-electric Class 4 commercial trucks for a sales order of $13.2 million to Momentum Groups. Momentum Groups can upfit the Bollinger B4 Chassis Cab with mobile EV chargers, a box truck, flatbed, service body or stake truck. Momentum Groups' strength is in its full-service national fleet program and mobile or permanent charging infrastructure for electric vehicles. Momentum will take possession of the vehicles after Bollinger Motors launches production in the second half of 2024.

09:11 EDT Fortune Brands acquires minority stake in Value Hybrid for cLOTO solutions - Fortune Brands Innovations announced it has acquired a minority stake and entered into a strategic partnership with Value Hybrid Globa, a software and SaaS startup focused on the delivery of connected lockout tagout or cLOTO solutions. This partnership will expedite Master Lock's ability to bring to market new and innovative products in the emerging field of cLOTO, and expand its presence in commercial safety solutions. Fortune Brands Chief Executive Officer Nicholas Fink said, "Connected lockout tagout is a significant opportunity for Fortune Brands. It is an attractive, emerging field that we are well positioned to lead in, given our highly recognized Master Lock brand, lockout tagout expertise, channel strength and commitment to invest in our highest-growth opportunities, which includes our expanding portfolio of connected products. We are excited to be partnering with Value Hybrid and bringing to market a best-in-class connected solution that will help to increase safety, improve efficiency, and enhance compliance, which impacts millions of people across the globe." Fortune Brands and Value Hybrid are uniquely situated to transform workplaces from mechanical to connected LOTO and expand the market for these solutions worldwide.

09:10 EDT Applied DNA Sciences receives approval for TR8 PGx teging service - Applied DNA Sciences announced that the New York State Department of Health approved the Company's TR8 PGx pharmacogenomic testing service. The Company is currently in discussions to provide large-scale testing to enterprise customers, healthcare networks, and concierge physicians seeking to add PGx testing to their test menu. Applied DNA's clinical laboratory subsidiary, Applied DNA Clinical Labs, is launching its PGx testing service to help guide healthcare providers to administer a wide range of medications relevant to cardiovascular, oncology, psychiatric, infectious disease, and pain management treatments based on a patient's unique genetics. The service is available by prescription only and will initially target the patient population of New York State. The TR8 PGx test analyzes 120 genetic targets across more than 30 genes to inform a healthcare provider how a patient may respond to a wide range of medications used to treat a variety of conditions, such as cardiovascular, oncology, psychiatric, and pain management. The test is administered via a simple cheek swab.

09:08 EDT VYNE Therapeutics announces dosing of first patients in Phase 1a trial of VYN202 - VYNE Therapeutics announced that the first healthy volunteers have been dosed in the Phase 1a trial of VYN202. VYN202 is an oral small molecule BD2-selective bromodomain and extra-terminal domain inhibitor that is being developed for the treatment of immuno-inflammatory diseases. Top-line data are expected in the second half of 2024. The Phase 1a trial is a first-in-human double-blind, placebo-controlled study in healthy volunteers and consists of single ascending dose and multiple ascending dose components. The trial is currently expected to enroll approximately 64 healthy adult subjects into five SAD and three MAD cohorts to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of VYN202.

09:07 EDT Carrier Global's climate and net zero targets validated by SBTi - Carrier Global's greenhouse gas emission reduction goals, including a target to reach net-zero greenhouse gas emissions by 2050, have been validated by the Science Based Targets initiative, or SBTi. A corporate climate action organization, SBTi enables companies and financial institutions worldwide to play their part in combating the climate crisis. SBTi's Target Validation Team has validated Carrier's near- and long-term greenhouse gas emission reduction goals as in line with a trajectory to limit global warming to 1.5 degrees C. Carrier's specific SBTi-validated targets are: reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year; reduce absolute scope 3 GHG emissions 25% within the same timeframe; reach net-zero greenhouse gas emissions across the value chain by 2050.

09:07 EDT ChargePoint, PCNA partner on Porsche Charging Service integration - ChargePoint and Porsche Cars North America, or PCNA, announced an agreement which will enable PCNA access to the ChargePoint network within the Porsche Charging Service. The collaboration will increase the number of chargers available to Porsche customers to more than 100,000 across North America.

09:06 EDT Webuy launches health supplement brand NEONE - Webuy Global announced its entry into the nutraceutical and longevity markets with the launch of NEONE, a premium health supplement brand committed to delivering high-quality nutritional supplements and health products. NEONE is a flagship brand exclusively developed by the Company and marks its strategic entry into the high-margin, multi-billion-dollar nutraceutical and longevity markets. The brand focuses on delivering the best health solutions to consumers through rigorous scientific research and innovation, ensuring the highest standards of quality, efficacy, and safety. NEONE offers a range of advanced health supplements that stand out for their high purity and potency. These supplements are designed to address issues such as fatigue, insomnia, and stress, with a particular focus on anti-aging and cellular health. NEONE NMN supplements provide targeted benefits for those looking to enhance their overall well-being and vitality. The NEONE NMN product contains nicotinamide, a form of Vitamin B3, which has been shown to support cellular energy production, improve mitochondrial function, and promote longevity. Clinical studies suggest that nicotinamide may help reduce the effects of aging, improve cognitive function, and enhance physical endurance.

09:05 EDT T-Mobile awarded $2.67B Navy contract - T-Mobile announced that it was chosen as a wireless solutions provider by the U.S. Department of the Navy as part of the $2.67B Spiral 4 contract. This new contract will give all Department of Defense agencies the ability to place orders for wireless services and equipment from T-Mobile for the next ten years. With Spiral 4, the Department of Defense will have the opportunity to leverage T-Mobile's 5G network for solutions that meet the evolving needs of government operations. The multiple-award contract includes voice, data, fixed wireless solutions, Internet of Things and mobility management solutions. It will help ensure robust and reliable connectivity for government activities - from mission critical communications to network solutions that serve military personnel and federal civilian agencies.

09:04 EDT Broadcom expands Broadcom Advantage Partner Program for VCSPs - Broadcom announced it is further enhancing customer-focused innovation through the expansion of the Broadcom Advantage Partner Program for VMware Cloud Service Providers in Europe. More than 50 VCSP Pinnacle Partners in Europe have joined the Broadcom Advantage Partner Program since February 2024. A Pinnacle partner designation signifies a cloud provider's technology expertise in providing VMware Cloud Foundation as a service, along with proficiency in solving customers' toughest challenges. Redcentric and Telia are just some of the newest VCSP Pinnacle Partners operating in Europe. roadcom VCSPs are able to offer customers more options by delivering sovereign cloud services that support data residency, high levels of compliance and other jurisdictional controls, while helping customers quickly achieve maximum value for VMware Cloud Foundation as they accelerate their transition to the cloud.

09:03 EDT Complete Solaria appoints Danie Foley as CFO - Complete Solaria announced the appointment of Daniel Foley as CFO, effective July 1, 2024. Mr. Foley will report to Complete Solaria's CEO, TJ Rodgers. Dan assumes the role of CFO effective July 1, 2024, and will be based at the company's Lehi, Utah office.

09:01 EDT RealReal opens installation of fake handbags on Canal Street - The RealReal unveils an installation of fake handbags at 301 Canal Street. In a moment where authenticity has never been so important, we're drawing attention to the pervasive counterfeit crisis and provocatively prompting passer-bys to ask themselves what's real, with the goal of starting a conversation about why it matters on a street synonymous with counterfeit culture. At first glance, the installation, created in collaboration with Mythology, may appear to be a new The RealReal store opening, but, at closer look, will reveal a 'store' whose stock consists entirely of non-shoppable luxury dupes confiscated during our authentication process; these 35 bags are impossible to decipher as fakes with the naked eye. They won't be for sale because this store will never open or sell anything. In fact, in an office above the store, reminiscent of the back rooms of Canal Street where the 'best' fakes are sold, we'll hold activations that honor the what's real, including an open invitation to turn in counterfeits one day each month for a chance to win the real thing from The RealReal and conversations with thought leaders from our community.

08:56 EDT WillScot Mobile Mini announces $500M senior secured notes offering - WillScot Mobile Mini Holdings announced that its indirect subsidiary, Williams Scotsman plans to offer, subject to market and other conditions, $500 million aggregate principal amount of senior secured notes due 2029. The Notes will be WSI's general second lien senior secured obligations, guaranteed on a senior secured basis by each of WSI's direct and indirect domestic subsidiaries that guarantees WSI's obligations under the existing ABL credit facility and WSI's direct parent, Williams Scotsman Holdings Corp. WSI intends to use the net proceeds of the offering to repay approximately $493.5 million of outstanding borrowings under its existing ABL credit facility and to pay related fees and expenses.

08:47 EDT BTU Metals to acquire two large gold exploration properties in Wawa gold area - BTU METALS CORP. (BTUMF) announces it has finalized the transaction to acquire a 100% interest in two large gold exploration projects in the active Wawa gold area of northern Ontario; the Echum Gold Project adjacent to Alamos Gold Inc. (AGI) and the Hubcap Gold Project adjacent to Red Pine Exploration. Each of the projects covers areas of historic gold mineralization and neither project has been the subject of significant or comprehensive exploration in recent years. The Echum property is adjacent along trend of the Alamos Gold Island Gold Mine property and the Hubcap property is adjacent along the geological trend of the gold mineralization that has been extensively drill tested by Red Pine Exploration. The consideration paid by BTU on closing for a 100% interest in the Echum and Hubcap properties was: C$25,000 and 5 million BTU treasury common shares. The only remaining obligation of the Company is in regards to undertaking to honour net smelter royalties to the original vendors.

08:44 EDT Foremost Lithium provides update on Peg North Property - Foremost Lithium Resource & Technology confirms further to its news release on June 29, 2022 in respect of the Company's option to acquire a 100% interest in the Peg North Claims located in the historic Snow Lake Mining District in Manitoba, that the Company has completed its third installment of the Option payment due on or before June 28, 2024. In accordance with the terms of the Option agreement, the third installment payment consisted of a cash payment of $100,000 and the issuance of 28,818 common shares at a deemed price of $3.47 per share, being the 30-day weighted volume average price of the Company's shares on the Canadian Securities Exchange. The shares are subject to a hold period of four months and one day expiring on October 13, 2024.

08:44 EDT Neuronetics announces participation at CTMSS - Neuronetics announced today their participation at the 12th Annual Meeting of the Clinical TMS Society, CTMSS, in London, England from June 13th-15th. Six posters and one oral presentation will feature data generated utilizing the NeuroStar TMS System. "We are thrilled to present this meaningful evidence at the Clinical TMS Society Annual Meeting and engage with TMS providers and researchers about recent advancements in our field," said Cory Anderson, Senior Vice President of Research & Development and Clinical Affairs. "Our extensive data and strong clinical presence establish NeuroStar as the leading TMS device, treating the highest number of patients and supporting providers in delivering exceptional patient care in clinical settings."

08:42 EDT Stellantis unveils multiple software-driven products for B2C, B2B customers - Stellantis is enhancing the mobility experience of consumer and commercial owners of vehicles from its 14 iconic brands with a steady stream of new connected features. That effort is delivering a boost to high-margin revenue from software and connected services, which has grown by 2.5 times since 2021, as the number of subscribers globally during that same period has increased to 5 million. Additionally, the monetizable car parc has grown 15% to 13.8 million vehicles, and Stellantis delivered more than 94 million over-the-air updates in 2023, adding and improving features in its existing vehicles. Stellantis has built its in-house capabilities to develop its own software, taking advantage of a global footprint of technology development hubs to work 24/7, building and customizing software products for each of the Company's vehicle platforms. The cutting-edge technology platforms are: STLA Brain: The foundational architecture offers centralized computing full over-the-air access to sensors and actuators. It reduces complexity, enabling the number of electronic control units (ECUs) per vehicle to be reduced by half to approximately 60 ECUs. New features can be developed in-house in less than six months, one-fourth the time of today's process. Technology readiness for integration is expected by the end of the year, with vehicle integration in 2025. STLA SmartCockpit: The platform ushers in a new generation of personalization and connected capabilities, powered by machine learning and AI technologies, giving users a seamless integration with their digital lives. A focus on simplified menus with fewer clicks for response to user inputs significantly improves ease of use. AI-enabled experiences give vehicle occupants more options in navigation, media, climate, lighting and productivity features. The key is a digital personal profile that knows your preferences and moves with you between Stellantis brand vehicles. Technology readiness for integration is expected by the end of the year. STLA SmartCockpit debuts in a Stellantis brand vehicle in 2025. STLA AutoDrive: The system leverages the capabilities of STLA Brain and STLA SmartCockpit to deliver useful and continuously updated Advanced Driver Assistance System technology that is intuitive, robust and inspires driver confidence. STLA AutoDrive targets significantly increasing the uninterrupted time and distance for ADAS-supported driving. The strategy includes industry-leading ADAS that provides drivers with both hands-off/eyes-off-the-road mobility and a fallback to limited hands-off/eyes-on-the-road cruising in the same system. Eyes-off technology readiness for integration is expected by the end of the year with the commercial launch in 2025.

08:40 EDT Nature's Miracle named exclusive U.S. distributor of Gro-Med products - Nature's Miracle has signed an agreement with Vaighai Agro to distribute its Gro-Med Line of Coco Coir Substrate products in the U.S. Vaighai, a subsidiary of Vaighai Agro Products, India, has over 40 years of experience in agro-industry. Gro-Med, a select brand of Vaighai, specializes in eco-friendly coco coir growing medium products. With this agreement, Nature's Miracle is allocated exclusive distribution of Vaighai's Gro-Med products within the U.S. effective immediately.

08:38 EDT eBay launches Venmo as payment option - eBay is expanding payment method choice at checkout by adding Venmo, the company announced. "The move to introduce new, popular and modern payment options aligns with the evolving preferences of today's digital natives. This convenient, simple, and safe payment method will bring eBay buyers in the U.S. even more choice and flexibility during the checkout experience... By integrating Venmo, a platform already embraced by more than 90 million highly engaged users, eBay taps into the modern and mobile-first consumer... The ability to pay with Venmo will be available to U.S. buyers on eBay.com and the eBay app in the coming week," eBay stated. Reference Link

08:37 EDT AAR Corp. expands electronics distribution relationship with OTTO Engineering - AAR Corp. has signed a territory expansion agreement that expands its Americas-based electronics distribution relationship with OTTO Engineering into the APAC region. Under the agreement, AAR will distribute OTTO's line of electromechanical switches, grips, and joysticks to the commercial and defense markets.

08:37 EDT Gen Restaurant's GEN Korean BBQ debuts all-new premium menu - GEN Restaurant Group, owner of GEN Korean BBQ, has debuted an all-new Premium Menu that is now available at GEN locations nationwide. The new Premium Menu featuring high-quality, top shelf proteins is available for an extra price per person or a la carte, allowing diners to choose from a wide variety of delectable dishes including beef, pork, chicken and seafood options while enjoying the engaging and interactive experience of being their own chef.

08:36 EDT Sharps receives $30M purchase order for prefillable copolymer syringe - Sharps Technology received a signed $30 million purchase order from Nephron Pharmaceuticals, representing their first 12 months of syringe purchase commitments. The purchase order includes deliveries for both the 10mL and 50mL specialty copolymer prefillable syringes that will be manufactured at the West Columbia site being acquired from Nephron. This assurance of supply is expected to support the planned expansion of the 503b operations at the Nephron site. Braden Miller, Sharps Director of Product Development, commented, "Sharps has developed an exciting alternative to glass syringes through the use of molded inert polymers, offering a high-quality solution compared to traditional glass syringe systems." Sharps prefillable polymer syringes have many of the same characteristics as traditional glass designs to support long term drug stability and increase shelf life for pharma and healthcare customers. However, polymer syringes can also be made into custom configurations with unique container closure systems; they can nearly eliminate breakage, minimize dead space, reduce contamination, excel in cold-chain storage, and support the development of novel devices including autoinjectors.

08:34 EDT VirTra simulators approved for DoD-funded research projects - VirTra announced that its simulators have been approved for Department of Defense, DoD, funding for research projects. This approval is supported by the results of a recent independent research study conducted by Ohio State University. The study, published by a third party, assessed VirTra's V-100 Simulator and confirmed that VirTra simulators can record shooting performance accurately and track individual progress over time reliably, thereby qualifying them as verified and consistent research tools. Researchers at Ohio State University studied 30 participants with varying degrees of rifle-handling experience to evaluate the V-100 Ballistic Simulator's capabilities as a training device and research tool. They found that the system accurately captured shooting data, decision-making, and reaction time down to millimeters and milliseconds. These significant findings support the use of VirTra's simulators as research tools and could lead to their use in a first-ever standardized performance score system for virtual reality ballistics training.

08:34 EDT Lisata announces full enrollment of pancreatic cancer cohort in CENDIFOX - Lisata Therapeutics announced the successful completion of patient enrollment for the pancreatic cancer cohort in the Phase 1b/2a CENDIFOX trial. This investigator-initiated trial, led by Dr. Anup Kasi at The University of Kansas Cancer Center, is evaluating the safety and efficacy of certepetide in combination with FOLFIRINOX-based therapies for pancreatic, colon, and appendiceal cancers. "The successful enrollment of the pancreatic cancer cohort represents another significant step forward in the clinical development of certepetide," said Dr. Kristen Buck, Lisata's Executive Vice President of Research and Development and Chief Medical Officer. "We are encouraged by the progress of the CENDIFOX trial and look forward to both the completion of enrollment in the remaining two cohorts and the reporting of results."

08:32 EDT CLPS acquires Shell Infotech in Singapore - CLPS, through its wholly-owned subsidiary, Ridik, has acquired 100% of the equity of Shell Infotech and its wholly-owned subsidiary Shell Infotech Consulting. This acquisition expands CLPS's client base and market share in Southeast Asia while strengthening its core IT competencies and service offerings, solidifying its commitment to global expansion. Established in 2003 and headquartered in Singapore, Shell Infotech is an IT consulting and managed services provider in Singapore and Malaysia. Following the acquisition, Shell Infotech's workforce will be integrated into CLPS's organizational structure, with its employees relocating to Ridik's office in Singapore. CLPS will maintain the Shell Infotech brand. The acquisition of Shell Infotech is expected to bring 27 new clients to the company and drive a projected 25% to 30% revenue increase in Southeast Asia.

08:32 EDT OSI Systems awarded $11M contract for radiation monitoring portals - OSI Systems announced that its Security division has received an order from an international customer valued at approximately $11M to provide customized radiation monitoring portals and related services and support.

08:32 EDT Inspira Technologies receives first purchase order for INSPIRA ART100 systems - Inspira Technologies announced that is has received the first purchase order from Glo-Med Networks for its INSPIRA ART100 systems, with the five product units expected to be shipped in the fourth quarter of 2024. The purchase order also provides for the potential purchase of an additional 20 systems, the timing of which is subject to further agreement between Inspira and Glo-Med.

08:25 EDT Ryder increases its long-term adjusted ROE to 20- 22% from 17-19% over cycle - Ryder Chairman & CEO Robert Sanchez and EVP & CFO John Diez, along with other members of the senior leadership team, will provide an in-depth review of Ryder's business transformation and will outline the next phase of the company's balanced growth strategy, which is focused on accelerating profitable growth supported by operational excellence and customer-centric innovation. In conjunction with Ryder's 2024 Investor Day, the company is increasing its long-term adjusted return on equity, ROE, target to a range of low twenties, 20% - 22% over the cycle, up from its prior target range of high teens, 17% - 19%, over the cycle. "The actions we've taken to de-risk the model, increase returns, and drive profitable growth under our balanced growth strategy have enabled Ryder to meaningfully outperform prior cycles. We are confident that our transformed business model, strategic initiatives, and expected benefits from the cycle upturn will enable us to exceed prior peak-cycle returns," says Sanchez.

08:21 EDT MetLife in pact with 3M to provide annuity benefits for obligations of $2.5B - MetLife announcedthat its subsidiary, Metropolitan Tower Life Insurance Company, has entered into an agreement with 3M to provide annuity benefits to approximately 23,000 retirees and beneficiaries in the 3M Employee Retirement Income Plan , the company's U.S. defined benefit pension plan, representing pension obligations of approximately $2.5B. "MetLife is pleased we were entrusted to provide guaranteed lifetime income to 3M retirees, as well as benefits to the retirees' spouses and beneficiaries," says Melissa Moore, senior vice president and head of Annuities at MetLife. "MetLife helped pave the way for today's pension risk transfer market more than 100 years ago and continues to be firmly committed to this business, leveraging our expertise at managing risk across a wide range of economic scenarios to remain an industry leader."

08:19 EDT Blink Charging receives 'In Process' FedRAMP status - Blink Charging achieved the "In Process" designation granted by the Federal Risk and Authorization Management Program for its EV charging solutions. Blink is presently listed as "In Process" in the FedRAMP Marketplace. Upon achievement of full accreditation for the Company's EV charging network, the Blink Network, government agencies will be able to contract with Blink or the Company's federal resellers for networked EV charging. Blink expects to reach full FedRAMP compliance status before the end of Q3 2024.

08:17 EDT Cero Therapeutics completes IND-enabling manufacturing activities for CER-1236 - CERo Therapeutics executed pre-IND manufacturing activities for its lead therapeutic, CER-1236. The completion of multiple manufacturing runs is required to meet safety and efficacy standards for drug administration in clinical trials, and this was the final required technical activity for the Company prior to completing its Investigational New Drug Application package. The Company anticipates sending the IND submission to the U.S. Food and Drug Administration in order to receive clearance to begin human trials with CER-1236 in the near term.

08:14 EDT Conifex Timber to curtail sawmill, planer for period of two weeks - Conifex is curtailing its sawmill and planer for a period of two weeks commencing June 17, 2024. The curtailment is the result of ongoing weather-related transportation challenges that have delayed spring log deliveries and resulted in lower than planned log inventories. It is anticipated that the reduced operating schedule will impact sawmill production capacity by approximately 8,500 Mfbm. Conifex continues to deliver spring decked logs from the southern portion of the Mackenzie TSA, and has commenced summer logging activities in the northern portion of the TSA. While weather may continue to impact log deliveries, Conifex currently anticipates resuming full operations at the sawmill and planer on July 2, 2024.

08:11 EDT Amwell announces co-CEO Schoenberg transitions to EV Chairman - Amwell announced that co-founder and visionary healthcare technology leader Roy Schoenberg, M.D., M.P.H., is transitioning from his role as president and co-CEO to become Executive Vice, EV, Chairman of Amwell's Board of Directors. Ido Schoenberg, M.D., will assume the role of sole Chief Executive Officer of Amwell.

08:09 EDT Zapata to participate in panel at D-Wave Qubits Conference - Zapata Computing (ZPTA) announced that two members of its executive team, Chief Revenue Officer Jon Zorio and Chief Technology Officer Yudong Cao, will be speaking at the D-Wave Qubits Conference on June 17, 2024. Zorio will join the conference's opening keynote discussion, hosted by Dr. Alan Baratz, President and Chief Executive Officer of D-Wave Quantum Inc. (QBTS), taking place at 8:30am EDT, while Zorio and Cao will be participating in a fireside chat hosted by The Boston Globe's Aaron Pressman at 3:50pm ET. Zorio will provide a high-level overview of Zapata AI's quantum and AI capabilities and how the company is helping its enterprise customers, which span multiple industries, solve some of their most complex industrial-scale problems during the keynote. Zorio's and Cao's fireside chat, titled The Quantum Leap in Generative AI: Implications for Industry, will focus on a range of topics, including the intersection of quantum and AI, the Company's partnership with D-Wave, use cases for quantum-enhanced generative AI across industries, the Boston AI tech scene and more.

08:09 EDT Archer Daniels, Bayer extend farming collaboration - ADM (ADM) and Bayer (BAYRY) announced an extension of their collaboration, working with farmers in a bid to drive the further adoption of regenerative agricultural practices in Europe. Last year, the companies embarked on a feasibility study to evaluate the impact of regenerative agriculture practices in curbing carbon emissions, increasing biodiversity and improving soil health. They worked with oilseed rape farmers covering approximately 9,000 hectares in Poland to conduct an in-depth on-farm risk assessment that evaluated carbon emissions reduction potential while building grower-specific roadmaps for the transition to regenerative agriculture. This preliminary assessment showed that carbon emissions from those hectares relying on at least one regenerative agricultural practice were 15% lower than those of conventional farms. The analysis suggests that emissions reductions could be up to 40% for farmers comprehensively adopting regenerative agriculture practices. As part of the next stage of the collaboration, the program will expand into a broader range of crops such as corn, wheat and barley, and geographically across Eastern Europe.

08:08 EDT Gorilla issues letter to shareholders - Gorilla Technology released a letter to its stockholders. The letter follows: "We, at Gorilla Technology, understand that the recent drop in our stock share price may have caused concern. However, I want to assure you that we are diligently navigating these turbulent waters and making significant progress in our core projects... We are on a roll and have recently secured three significant projects in Taiwan, focused on one of the very first Roaming Lawful Interception solutions, Smart Port solutions to operational efficiency and Criminal Investigation systems... Despite these successes, I acknowledge the concern regarding our stock price... In line with our commitment to transparency and in compliance with SEC regulations, we have filed a Form 6-K detailing an offering of our ordinary shares for approximately $12.0 million. We raised these funds to fuel the ambitious projects that are the lifeblood of our vision, particularly our monumental projects in Taiwan and Egypt.... Furthermore, we are actively engaged in negotiations on several material contracts. These potential partnerships are anticipated to be transformative... We understand that stock price fluctuations can be unsettling. We ask for your trust and patience as we navigate this temporary phase. We are dedicated to driving value for all our stakeholders and are confident that our efforts will lead to long-term success."

08:07 EDT Vivani Medical announces FDA clearance of NPM-119 IND, lifts clinical hold - Vivani Medical announced the FDA has cleared the investigational new drug application, or IND, and lifted the clinical hold on NPM-119 to allow initiation of LIBERATE-1, a Phase 1 clinical trial to assess the safety, tolerability and pharmacokinetics of NPM-119, the company's miniature, six-month GLP-1 implant in development for the treatment of type 2 diabetes.

08:06 EDT Collegium obtains six month extension of U.S. pediatric exclusivity for Nucynta - Collegium Pharmaceutical announced that the U.S. Food and Drug Administration, FDA, has granted pediatric exclusivity for Nucynta and Nucynta ER. In 2023, FDA granted New Patient Population exclusivity for Nucynta in pediatrics, extending the period of U.S. exclusivity from June 27, 2025, to July 3, 2026. FDA's grant of pediatric exclusivity now extends exclusivity of the Nucynta Franchise an additional six months, to January 3, 2027, for Nucynta and December 27, 2025, for Nucynta ER. "We are pleased with FDA's grant of pediatric exclusivity for the Nucynta Franchise," said Thomas Smith, M.D., Collegium's Chief Medical Officer. "This grant of pediatric exclusivity enhances the value of the Nucynta franchise and bolsters our near-term outlook. Collegium is proud to lead with science in support of people living with serious medical conditions and the communities we serve."

08:05 EDT Ashford Hospitality sells two hotels for $17.5M - Ashford Hospitality has closed on the sale of the 90-room SpringHill Suites and the 86-room Fairfield Inn located in Kennesaw, Georgia for $17.5M. The sale price represented a 4.8% capitalization rate on trailing 12-month net operating income through April 2024. The hotels were encumbered with a mortgage loan that had an outstanding balance of approximately $10.8M. All remaining proceeds from the sale will be used for general corporate purposes, including the pay down of the company's strategic financing.

08:04 EDT RTX's Raytheon awarded $506M NASA contract - Raytheon, an RTX business, was awarded a $506M contract from NASA to design and build the Landsat Next Instrument Suite, which includes three next generation space instruments, with an option for an additional instrument. The instrument suite will perform Earth observation from three identical observatories from Low-Earth orbit. Through multispectral imaging technology, LandIS will collect images of the Earth's surface every six days, detecting natural and human-induced changes.

08:03 EDT Lument Finance Trust raises quarterly dividend to 8c from 7c per share - Lument Finance Trust announced the declaration of a cash dividend of 8c per share of common stock with respect to the second quarter of 2024, which represents a 14% increase over the first quarter of 2024 dividend of 7c per share. The dividend is payable on July 15 to common stockholders of record as of the close of business on June 28.

08:02 EDT Conduit Pharmaceuticals to join Russell 3000 Index - Conduit Pharmaceuticals announced the Company is set to join the broad-market Russell 3000 Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024, according to a preliminary list of additions posted by FTSE Russell on Friday, May 24th, 2024.

08:01 EDT Amazon commits $230M to generative AI startups - Amazon Web Services announced a $230M commitment for startups around the world to accelerate the creation of generative AI applications. This will provide startups, especially early-stage companies, with AWS credits, mentorship, and education to further their use of artificial intelligence, or AI, and machine learning, or ML, technologies. Part of the new commitment will fund the second cohort of the AWS Generative AI Accelerator, a program that provides hands-on expertise and up to $1M in credits to each of the top 80 early-stage startups that are using generative AI to solve complex challenges. Applications for the AWS Generative AI Accelerator open today and will be accepted until July 19.

08:00 EDT Mogo in deal with with Postmedia Network to launch a new content channel - Mogo announced a new strategic partnership with Postmedia Network, a Canadian news media company representing more than 130 brands across multiple print, online, and mobile platforms, to launch a new content channel with news and information on wealth-building. The channel will be aimed at educating Canadians on how to invest, accumulate wealth, and manage it effectively to achieve their financial goals, addressing a gap in the availability of quality educational content from existing financial services providers. According to the J.D. Power 2023 Canada Retail Banking Advice Satisfaction Study, "Investment and retirement advice is the most frequent type of advice both desired and received by bank customers and interest for this topic is on the rise" . With a joint focus on educating current and future investors, Postmedia is establishing a new digital channel on the Financial Post platform, with distribution extending to other Postmedia properties..."We're very pleased to be renewing our long-running partnership with Mogo as part of this unique initiative," said Andrew MacLeod, President and Chief Executive Officer, Postmedia. "This new channel represents the perfect alignment between Mogo's vision for the future and Postmedia's commitment to delivering indispensable, trusted content to Canadians." Under the new agreement, Mogo will issue 500,000 warrants to Postmedia, each such warrant entitling Postmedia to acquire one Mogo share at a price of $2.15 for a period of three years from the date of issue. Issuance of the warrants is subject to TSX approval.

07:36 EDT FSD Pharma enters exclusive option agreement with USC - FSD Pharma entered into an exclusive option agreement with the University of Southern California to evaluate dietary supplement technology for commercialization. The option agreement, signed June 11, 2024, allows FSD Pharma to exclusively evaluate the novel technology for a 6-month term. At the end of this term, FSD Pharma will have the option to either extend it for an additional 6 months or to sign an exclusive license for the technology with USC. This novel technology is being evaluated for the potential to further increase the effectiveness of certain ingredients currently present in unbuzzd. unbuzzd is a scientifically formulated blend of vitamins, minerals, and herbs engineered to expedite alcohol metabolism, facilitate faster recovery from alcohol consumption, and simultaneously enhance mental alertness to those individuals who consume it.

07:30 EDT Alta Global partners with former UFC fighter Jessica-Rose Clark - Alta Global Group announced a new partnership with esteemed Australian mixed martial artist Jessica-Rose Clark. This collaboration marks another step forward in Alta's mission to engage 640 million MMA fans globally, converting their passion into active participation.

07:25 EDT Electrovaya announces update to solid-state battery development - Electrovaya announced an update on its solid-state battery program at its annual Battery Technology Day event. Updates regarding Electrovaya's solid state battery program included the following: Development of a scalable and cost-effective lithium ion conducting ceramic that has demonstrated good performance: ionic conductivity in the range of ~8.10-4 S/cm; and work continues to further improve conductivity and scale up of production. Development of a proprietary separator that uses Electrovaya's in-house ion conducting ceramic material. The separator incorporates a scalable manufacturing process and the Company has made progress in increasing the separator size to meet the needs of commercially viable cells. Progress in the development of pouch cells with stable cycling performance.

07:22 EDT Moderna announces Phase 3 trial of mRNA-1283 met primary efficacy endpoint - Moderna announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine, has met its primary efficacy endpoint, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax. The Company also announced that higher efficacy was observed in adults 18 years of age and older compared to Spikevax, with a consistent trend observed in the subset of adults age 65 and older. Positive interim immunogenicity results for mRNA-1283 in this study were previously reported in March 2024. The ongoing Phase 3 clinical trial is a randomized, observer-blind, active-controlled study of approximately 11,400 individuals aged 12 years and older. Half of the participants received a 10 undefined dose of mRNA-1283, while the other half received a 50 undefined dose of mRNA-1273. Today's vaccine efficacy data are consistent with the previously announced immunogenicity results from the study, which showed that mRNA-1283 had higher neutralizing antibody responses against both Omicron BA.4/5 and ancestral SARS-CoV-2 than mRNA-1273, with the highest geometric mean titer ratios observed in adults and in the subset of participants aged 65 years and older. In the trial, mRNA-1283 was found to have a similar safety profile to Spikevax. The most commonly solicited side effects were injection site pain, fatigue, headache and myalgia. Moderna's combination vaccine candidate against influenza and COVID-19, mRNA-1083, includes mRNA-1283. That vaccine candidate recently announced positive results in its separate Phase 3 trial. Moderna plans to present the Phase 3 clinical data for mRNA-1283 at an upcoming conference as well as submit it for publication. The Company will also engage with regulators on the next steps for the program.

07:19 EDT Draganfly enters partnership with First Atlantic Nickel - Draganfly has been selected by First Atlantic Nickel Corp. to utilize its proprietary survey technologies and services to help explore for what could be the first awaruite and district scale nickel project in Atlantic Canada. Working with management and experts at First Atlantic Nickel, Draganfly's drone, sensors and personnel have been specifically tailored to help maximize the potential success of this important project. Awaruite, a highly magnetic nickel-iron alloy, will be the primary target of initial surveys utilizing Draganfly's advanced drone sensors, which will be instrumental in rapidly identifying the strongest zones of awaruite nickel mineralization within the extensive Atlantic Nickel Project.

07:16 EDT Reunion Gold board recommends securityholders vote for arrangement resolution - Reunion Gold has filed and will commence mailing of the joint management information circular and related materials for its annual general and special meeting of the holders of Reunion Gold common shares and the holders of options to purchase Reunion Gold common shares, to be held at the offices of Stikeman Elliott LLP, located at 5300 Commerce Court West, 199 Bay St. Toronto, Ontario, M5L 1B9, on July 9, 2024, at 10:00 a.m. At the Meeting, Reunion Gold Voting Securityholders will be asked to consider and vote on, among other things, a special resolution approving a statutory plan of arrangement, subject to the terms and conditions of an arrangement agreement dated April 22, 2024, and amended as of June 7, 2024, entered into between Reunion Gold, G Mining Ventures, and Greenheart Gold. Pursuant to the Arrangement, a new entity to be incorporated to hold and manage the combined business of Reunion Gold and GMIN will acquire all of the issued and outstanding common shares in the capital of Reunion Gold and all of the issued and outstanding common shares in the capital of GMIN by way of a proposed plan of arrangement under Section 192 of the Canada Business Corporations Act, in an all-equity business combination transaction. Immediately following the completion of the Arrangement: Reunion Gold Shareholders will receive 0.07125 of a common share of New GMIN and 0.05 of a common share of Spinco for each Reunion Gold Share held; holders of GMIN Shares will receive 0.25 of a New GMIN for each GMIN Share held; Reunion Gold will assign and transfer to Spinco all of its assets other than the Oko West project located in Northwest Guyana, and $15 million in cash; existing Reunion Gold Shareholders and GMIN Shareholders will own approximately 43% and 57%, respectively, of New GMIN on a fully-diluted in-the-money basis prior to a concurrent US$50 million equity financing; and Reunion Gold Shareholders and New GMIN will own 80.1% and 19.9% respectively, of the outstanding Spinco Shares. The Arrangement will require approval by: at least 66 2/3% of the votes cast by the Reunion Gold Shareholders, present in person or represented by proxy at the Meeting; at least 66 2/3% of the votes cast by the Reunion Gold Voting Securityholders, present in person or represented by proxy at the Meeting, voting together as a single class; and a majority of the votes cast by the Reunion Gold Shareholders present in person or represented by proxy at the Meeting, excluding the votes attached to the Reunion Gold Shares in accordance with Section 8.1(2) of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Arrangements. Directors and members of senior management of Reunion Gold and La Mancha, as well as two subsidiaries of, and a trust controlled by, Dundee Corporation, who in the aggregate own approximately 29% of the outstanding Reunion Gold Shares, have entered into voting support agreements pursuant to which they have agreed to vote their shares in favor of the Arrangement, subject to the terms thereof. The special committee of the Reunion Gold board of directors formed for the purpose of considering the Arrangement, unanimously determined, after careful consideration, including a thorough review of the Arrangement Agreement, the fairness opinions provided by BMO Capital Markets and SCP Resource Finance LP, and other matters considered relevant, that the Arrangement is in the best interests of Reunion Gold. Accordingly, the Reunion Gold Special Committee unanimously recommended that the Reunion Gold Board approve the Arrangement Agreement and recommend that Reunion Gold Voting Securityholders vote in favour of the Reunion Gold Arrangement Resolution. The Reunion Gold Board unanimously recommends that Reunion Gold Voting Securityholders vote FOR the Arrangement Resolution.

07:11 EDT Vast, Mabanaft advance Port Augusta green methanol project - Vast announced it has signed a Joint Development Agreement, JDA, with global energy company Mabanaft to advance Solar Methanol 1, SM1, a CSP-powered green methanol reference plant. Located in South Australia at the Port Augusta Green Energy Hub, SM1 will have the capacity to produce 7,500 tonnes of green methanol each year. Methanol is one of the most versatile hydrogen derivatives which, if produced using clean energy, has the potential to decarbonise several hard-to-abate industries, including shipping and aviation.

07:11 EDT Asante Gold announces rerouting of Bibiani-Goaso Highway - Asante Gold announces that the Bibiani-Goaso Highway has been rerouted following the recent completion of two detour roads, allowing for the further development of the open pit and the underground at the Bibiani Gold Mine. This vital step advances the Company's plans to grow gold production at Bibiani to more than 250,000 ounces per year, with cumulative production of 1.2 million ounces of gold anticipated over the next five years, at lower all-in sustaining costs, as detailed in the 2024 Bibiani Technical Report. Rerouting the highway gives the Company access to approximately 170,000 ounces of contained gold from the Main Pit in the next 12 months and supports planning to process 250,000 ounces from 2026 fiscal year onwards. The oxide mineralization from near surface at the southern portion of the Main Pit allows higher gold recovery while the Sulphide Recovery Plant is being installed. Re-routing the highway creates the ability to increase monthly production to over 20,000 ounces within eight months. Over the longer term, it supports the Company's plans to explore and extend mine life well into the next decade at Bibiani. Rerouting of the Bibiani-Goaso Highway became possible following the successful planning, design and construction of two detour roads which provide easier access to commuters and represent a major accomplishment for Asante. Planning of the two detour roads required extensive consultation and support of key stakeholders such as Ghana's Ministry of Roads and Transport, the Ghana Highway Authority, the Department of Feeder Roads, Regional Ministry, traditional authorities, local community committees, the Bibiani-Anhwiaso-Bekwai Municipal Assembly, transport organisations, community members and other stakeholders. Asante thanks all stakeholders at Bibiani for their constructive participation in the process.

07:09 EDT BioRestorative in discussions for potential license agreement for ThermoStem - BioRestorative Therapies reported that it has had substantive discussions with an undisclosed commercial stage regenerative medicine company with regard to a license of BioRestorative's allogeneic, off-the-shelf ThermoStem metabolic intellectual property. No assurances can be given that a license agreement will be entered into whether on commercially reasonable terms or otherwise. The Company does not intend to make any further announcements with regard to the license unless and until an agreement is entered into. "It has been captivating to watch the scale, scope and speed with which potential license partners have begun to show interest in our proprietary off-the-shelf ThermoStem platform," said Lance Alstodt, BioRestorative's Chief Executive Officer. "We are particularly pleased that our pioneering animal studies, which demonstrated that BADSCs show promise in correcting the weight gain and hyperglycemia associated with high fat feeding, and that our 3D scaffolds, which are capable of retaining viable transplanted cells for at least five weeks post-implantation, have attracted the caliber of commercial stage regenerative medicine company with which we are now engaged in substantive licensing discussions."

07:09 EDT Critical Metals releases investor webcast on Tanbreez acquisition - Critical Metals announced that a webcast hosted by management is now available on the Investor Relations section of the Company's website. During the webcast, Critical Metals Corp's CEO and Chairman, Tony Sage, discusses the history of the Company, its vision and broader strategy. He explains the importance of Critical Metal Corp's recently announced plans to acquire Tanbreez, one of the world's largest known rare earth assets. Mr. Sage provides an overview of this foundational rare earth asset in addition to an overview of Critical Metals Corp's other projects.

07:07 EDT Planet Fitness announces $280M accelerated share repurchase agreement - Planet Fitness announced that it has entered into a $280M accelerated share repurchase agreement with Citibank, N.A. The company will acquire shares under the ASR Agreement as part of its $500M share repurchase authorization previously announced on November 8, 2022. As of June 13, 2024, before giving effect to the ASR Agreement, approximately $355M remained available for share repurchases pursuant to the 2022 Share Repurchase Program.

07:07 EDT Climb Channel Solutions announces partnership with Flashpoint - Climb Channel Solutions, a wholly owned subsidiary of Climb Global Solutions, announced the launch of their partnership with Flashpoint, the industry leader in threat data and intelligence. This strategic partnership aims to empower mission-critical organizations to proactively and decisively confront security and intelligence challenges with the most powerful data at the core, ensuring the safety of people, places, and assets. "As threat actors become smarter, and threats become more complex, it is critical that Climb continues to provide our partners with the best technologies to protect their customers' data," says Dale Foster, CEO of Climb Channel Solutions. "By partnering with Flashpoint, we enable partners and their customers with top threat intelligence solutions to quickly and easily make decisions and take action."

07:06 EDT nLight executes LOI for joint strategic technology cooperation with EOS - nLIGHT announced an executed Letter of Intent or LOI to pursue a joint strategic technology cooperation, making nLIGHT's beam shaping lasers available in EOS' metal AM systems. The cooperation between nLIGHT and EOS includes the implementation of a series of complementary laser-based technologies to optimize the AM light engine for robust industrial 3D printing production. nLIGHT and EOS plan to make beam shaping and light engine optimization capabilities available digitally, enabling customers to access different beam profiles via EOS software to activate higher productivity printing. AMCM, an EOS Group company focused on customized AM solutions, has already made the programmable AFX laser available in its metal AM systems. The LOI between nLIGHT and EOS represents an evolution of this relationship. nLIGHT's programmable AFX laser offers seven different beam profiles in a single laser, ranging from an 85 micron spot size for maximum precision contours, to a 210 micron ring profile for faster printing, improved process stability and reduced soot and spatter..."We are always researching industry leading technologies to advance the industrialization of additive manufacturing to meet the emerging application demands and exceed customer expectations," said Marie Langer, CEO of EOS. "The flexibility and performance gains of nLIGHT's beam shaping and laser technologies gives us an unprecedented advancement in metal AM systems and will allow our customers to unleash a new level of productivity." nLIGHT and EOS plan to make the AFX-enabled machines available to customers in late-2024

07:04 EDT Priceline selects Omnicom's PHD as new media agency of record - Priceline announced the appointment of Omnicom Media Group's PHD as its new brand media agency of record. The announcement follows a competitive review to select a media agency partner to drive customer growth and brand equity for the iconic online travel agency.

07:04 EDT Repligen announces CEO Hunt transition to Executive Chair, Loeillot to succeed - Repligen announced that its Board of Directors has approved the planned transition of Tony Hunt from Chief Executive Officer, CEO, to Executive Chair, effective September 1, 2024. The Company's Board has appointed Olivier Loeillot to succeed Mr. Hunt in the role of President and CEO, also effective September 1, 2024. At the same time, Loeillot, who joined the Company in October 2023 as President and Chief Commercial Officer, will join the Repligen Board, while current Board Chair Karen Dawes will assume the role of Lead Independent Director.

07:03 EDT Aldeyra completes enrollment in reproxalap trial - Aldeyra announced the completion of enrollment in a Phase 3 dry eye chamber clinical trial of topical ocular 0.25% reproxalap, an investigational RASP modulator, for the treatment of dry eye disease. The trial is designed to enable potential resubmission of a dry eye disease New Drug Application, or NDA, in the second half of 2024.

07:01 EDT Pasithea Therapeutics begins dosing cohort 2 in Phase 1 trial of PAS-004 - Pasithea Therapeutics announced that an independent Safety Review Committee has completed its safety review of data from the first dose cohort treated in the ongoing Phase 1 clinical trial of PAS-004 in patients with MAPK pathway driven advanced solid tumors with a documented RAS, NF1 or RAF mutation or patients who have failed BRAF/MEK inhibition. The SRC recommended that the trial escalate to the next dose level - 4mg - without modifications. This recommendation was based on the absence of any dose limiting toxicities or clinically relevant treatment-emergent adverse events in the initial cohort of 3 patients. The company has now completed enrollment and initial dosing of 3 patients in the second cohort. The company expects to present initial safety and pharmacokinetic data in Q3. The primary objective of the study is to assess the safety and tolerability of PAS-004, with secondary objectives including PK and PD parameters, an evaluation of the preliminary anticancer activity of PAS-004 and defining the preliminary recommended Phase 2 dose.

06:47 EDT Barnes Aerospace, Pratt & Whitney Canada sign long-term agreement - Barnes Aerospace, a business of Barnes (B), and RTX's (RTX) Pratt & Whitney Canada announced a significant milestone: a long-term extension of a repair services agreement. As industry leaders in aerospace aftermarket solutions, the companies are committed to partnering on the maintenance, repair, and overhaul of highly complex parts used in aero engine cases, rotating components, shrouds, and seals. The newly signed extension continues Barnes Aerospace's and Pratt & Whitney Canada's longstanding business relationship, which dates back to the 1970s. The agreement allows the companies to collaborate further on developing repairs for new and existing aerospace engines.

06:38 EDT Quarterhill M5 Speed enforcement camera gains approval in Germany, Austria - Quarterhill announced that its subsidiary, VDS Verkehrstechnik, has been awarded a homologation certificate by the Physikalisch-Technische Bundesanstalt Nationales Metrologieinstitut, Germany's renowned national metrological institute, and a certificate renewal by Bundesamt fur Eich- und Vermessungswesen, Austria's Federal Office of Metrology and Surveying. These certifications will pave the way for German and Austrian sales of the M5 Speed enforcement camera.

06:32 EDT MRC Global selected by Exxon as primary pipe, valves and fitting provider - MRC Global (MRC) subsidiary MRC Global has signed an agreement to be the primary provider of pipe, valves and fitting products and services to ExxonMobil (XOM) in North America. The agreement includes all of ExxonMobil's North America upstream and downstream facilities for maintenance, repair and operations as well as project work.

06:10 EDT MongoDB teams with Bendigo, Adelaide Bank to modernize core banking technology - MongoDB announced that Bendigo and Adelaide Bank has partnered with MongoDB to modernize its core banking technology with MongoDB Atlas as the keystone of an ambitious application modernization initiative. During the initiative, the bank: reduced the development time required to migrate a core banking application off of a legacy relational database to MongoDB Atlas by up to 90%. Migrated onto MongoDB Atlas at one-tenth of the cost of a traditional legacy-to-cloud migration. Automated repetitive developer tasks with new AI tooling in order to accelerate developers' pace of innovation.

06:05 EDT Beam Global's solar EV charging systems selected by city of Vacaville, CA - Beam Global announced that the City of Vacaville has deployed three EV ARC solar-powered EV charging systems for use by the general public. The order aligns with the City of Vacaville's continued commitment to sustainable energy and conservation efforts with its General Plan and Energy and Conservation Action Strategy. Beam EV ARC systems are deployed with no electrical work, no construction and no utility bill, reducing the City's costs by eliminating construction, electrical upgrades, operational disruptions and ongoing utility bills.

06:03 EDT Bitfarms signs agreement to develop up to 120 MW in the U.S. - Bitfarms announced an agreement to develop up to 120 MW of power capacity and lease a site in Sharon, Pennsylvania. The power supply dynamics offer load flexibility suitable for Bitcoin mining, along with opportunities for participation in demand response and other curtailment programs, enabling Bitfarms to improve its corporate electricity price and further diversify its revenue streams. This U.S. expansion raises the company's 2025 power capacity to 648 MW, 170% growth from current capacity and 47% growth from targeted year-end 2024 capacity, and the company projects 2025 guidance of over 35 EH/s. The existing structure will be retrofitted with the expectation of bringing 12 MW online in Q4 2024 and the remaining load online in the second half of 2025. Immediate capacity for 12 MW with development capacity up to 120 MW in 2025.

05:32 EDT Tesla jumps 5% to $186.97 after Musk says pay package passing by 'wide margin'

05:27 EDT Musk says both Tesla shareholder resolutions 'passing by wide margins' - Tesla CEO Elon Musk said overnight via X that both Tesla "shareholder resolutions are currently passing by wide margins!" Shareholders are voting on Musk's compensation package as well as the company reincorporating to Texas. Reference Link

05:18 EDT Nokia appoints Lorna Gibb chief people officer, Ricky Corker to step down - Nokia announced the appointment of Lorna Gibb as chief people officer and member of the group leadership team, effective immediately. In addition, Ricky Corker, who has served as Nokia's chief customer experience officer since 2021, will step down and leave the company effective June 28. Lorna Gibb joined Nokia in 2020 and has been Nokia's interim chief people officer since March. Gibb will be based in Finland and reports to Nokia's president and CEO, Pekka Lundmark. In addition, Ricky Corker, who has served as Nokia's chief customer experience officer since 2021, will step down and leave the company on June 28. Corker's departure follows Nokia's decision to increase operational autonomy and move into a streamlined operating model, where the customer experience organization has been embedded into the business groups from the start of 2024.

05:07 EDT Stellantis backs AOI, free cash flow and capital return targets at investor day - At the first Stellantis investor day in Auburn Hills, Michigan, CEO Carlos Tavares will outline the company's nine key strategic differentiators. CFO Natalie Knight and other members of the top executive team will share updates on the company's regions, functions and brands. Stellantis management confirms its 2024 financial guidance and capital return plan: double-digit adjusted operating Income, or AOI, margin and positive industrial free cash flows. Delivering EUR 7.7B in dividends and buybacks in 2024. CFO Natalie Knight will reiterate more specific color on first and second-half expectations within the 2024 period: first half outlook of 10%-11% AOI margin, with industrial free cash flows visibly below the prior year period. Significant product launches, cost initiatives and anticipated improvement in working capital together support H2 sequential improvement opportunity in AOI and industrial free cash flow. Stellantis is also updating its capital plan in several significant ways: setting target liquidity levels of 25%-30% of revenues for the medium-term, shifting focus to capital efficiency and supporting strong shareholder returns. The company will continue to use share buybacks and ordinary dividends to return excess cash to shareholders. In 2025, Stellantis will target the upper range of its 25-30% dividend payout policy vs. 25% in recent years.